These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 8066357)

  • 21. [All mortality by cause of death. The challenge of coronary prevention].
    Fernández-Cruz A
    Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary prevention in hypercholesterolemia. High HDL cholesterol levels and female gender underestimated protective factors].
    Wahlberg G
    Lakartidningen; 2006 Jan 18-24; 103(3):131-4. PubMed ID: 16465756
    [No Abstract]   [Full Text] [Related]  

  • 24. [The facts about cholesterol (condensed translation and comments of the common declaration of AHA and NHLBI)].
    Jacotot B; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():83-6. PubMed ID: 1296550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
    Brewer HB
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Secondary prevention in patients with a coronary disorder: wider indication for cholesterol-lowering drugs].
    Peters RJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(12):604-6. PubMed ID: 7700402
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of lowering cholesterol on mortality].
    Schmidt JG
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2150-5. PubMed ID: 8266036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypercholesterolemia and coronary disease: intervention strategies].
    Brunelli C; Spallarossa P; Saccani A; Corsiglia L; Ghigliotti G; Caponnetto S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):303-8. PubMed ID: 1841785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage.
    Prescrire Int; 2004 Oct; 13(73):176-9. PubMed ID: 15499698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methodology of phase III clinical trials of hypocholesteremic agents. Do any reliable substitution criteria exist?].
    Espié J
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():121-4. PubMed ID: 1285690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol-lowering diets. A review of the evidence.
    Denke MA
    Arch Intern Med; 1995 Jan; 155(1):17-26. PubMed ID: 7802517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cholesterol--the main risk factor in ischemic heart disease].
    Heyden S; Kroos S
    Schweiz Rundsch Med Prax; 1988 Nov; 77(48):1312-7. PubMed ID: 3064242
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypercholesterolemia: a reversible risk factor for coronary heart disease.
    Mishkel MA
    CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008
    [No Abstract]   [Full Text] [Related]  

  • 39. [Should men aged 20 to 30 years with hypercholesterolemia be managed in the same way as older men?].
    Delahaye F; Emmerich J; Bruckert E; Thomas D; Richard JL
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():67-72. PubMed ID: 1296547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
    Zweig S
    J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.